Promising results Halt phase III studies of idelalisib.
作者信息
Inman Silas
出版信息
Am J Manag Care. 2014 Feb;20(2 Spec No.):E9.
PMID:25764575
Abstract
摘要
相似文献
1
Promising results Halt phase III studies of idelalisib.喜人的结果使idelalisib的III期研究暂停。
Am J Manag Care. 2014 Feb;20(2 Spec No.):E9.
2
Idelalisib for chronic lymphocytic leukemia.idelalisib用于治疗慢性淋巴细胞白血病。
Clin Adv Hematol Oncol. 2014 Dec;12(12):846-8.
3
Idelalisib: targeting PI3Kδ in B-cell malignancies.idelalisib：靶向B细胞恶性肿瘤中的PI3Kδ
Lancet Oncol. 2014 Mar;15(3):e108. doi: 10.1016/s1470-2045(14)70052-x.
4
Idelalisib for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma.依鲁替尼治疗慢性淋巴细胞白血病/小淋巴细胞淋巴瘤。
Future Oncol. 2016 Sep;12(18):2077-94. doi: 10.2217/fon-2016-0003. Epub 2016 Jun 21.
5
Idelalisib, ibrutinib show benefits in CLL.idelalisib和ibrutinib在慢性淋巴细胞白血病中显示出疗效。
Cancer Discov. 2014 Apr;4(4):382. doi: 10.1158/2159-8290.CD-NB2014-025. Epub 2014 Feb 20.
6
Idelalisib approved for three blood cancers.idelalisib获批用于三种血癌。
Am J Health Syst Pharm. 2014 Sep 1;71(17):1430. doi: 10.2146/news140061.
7
Risk factors for grade 3/4 transaminase elevation in patients with chronic lymphocytic leukemia treated with idelalisib.接受idelalisib治疗的慢性淋巴细胞白血病患者发生3/4级转氨酶升高的危险因素。
Leukemia. 2020 Dec;34(12):3404-3407. doi: 10.1038/s41375-020-0974-y. Epub 2020 Jul 12.
8
Idelalisib rapidly improves platelet function tests in patients with chronic lymphocytic leukaemia.idelalisib可迅速改善慢性淋巴细胞白血病患者的血小板功能测试。
Br J Haematol. 2018 Dec;183(5):825-828. doi: 10.1111/bjh.15052. Epub 2018 Jan 7.
9
Idelalisib: a review of its use in chronic lymphocytic leukaemia and indolent non-Hodgkin's lymphoma.依鲁替尼：在慢性淋巴细胞白血病和惰性非霍奇金淋巴瘤中的应用评价。
Target Oncol. 2015 Mar;10(1):141-51. doi: 10.1007/s11523-015-0359-8. Epub 2015 Feb 1.
10
Sequential disseminated aspergillosis and pulmonary tuberculosis in a patient treated by idelalisib for chronic lymphocytic leukemia.一例接受idelalisib治疗慢性淋巴细胞白血病患者发生的序贯播散性曲霉病和肺结核
Med Mal Infect. 2017 Jun;47(4):293-296. doi: 10.1016/j.medmal.2016.10.001. Epub 2016 Nov 3.
Zotero 插件